Joao A. Neto-Machado
3900 Bandeirantes Avenue
Ribeirao Preto, SP 14040900, Brazil
Ribeirao Preto, SP 14040900, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 149 publications
Multifunctional nanoparticles for co-delivery of elacridar and paclitaxel for breast cancer local treatment.
Journal: International journal of pharmaceutics
Published: July 21, 2026
The blood remembers: HSC-iM and the cancer continuum.
Journal: Blood cancer journal
Published: June 25, 2026
O-GlcNAc transferase as an oncogenic regulator in hematologic malignancies: Mechanisms, disease contexts, and therapeutic perspectives.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 24, 2026
Beyond apoptosis: LSC state dictates metabolic and anti-apoptotic vulnerabilities.
Journal: Cell stem cell
Published: May 14, 2026
Molecular and Antiangiogenic Effects of Paclitaxel-Loaded Nanoparticles: Influence of the Nanocarrier Type.
Journal: Molecular pharmaceutics
Published: March 06, 2026
Quizartinib-induced resistance drives clonal emergence of MV4-11 cells with molecular alterations enabling multidrug antileukemic escape.
Journal: European journal of pharmacology
Published: February 21, 2026
Starving leukemia: nicotinamide phosphoribosyltransferase-dependent nicotinamide adenine dinucleotide salvage links metabolic vulnerability to therapeutic sensitivity in acute myeloid leukemia.
Journal: Translational cancer research
Published: February 05, 2026
A mitochondrial-based prognostic score for risk stratification in acute myeloid leukemia.
Journal: Blood research
Published: January 12, 2026
The murine Irs1 knockout model, generated by the spontaneous Irs1S57X mutation in homozygosity, exhibits high embryonic lethality, limiting studies of adult hematopoiesis.
Journal: Hematology, transfusion and cell therapy
Published: January 09, 2026
Does coordinated targeting of metabolism and autophagy, modulated by microtubule dynamics, influence therapeutic vulnerability to eribulin in glioblastoma?
Journal: Translational cancer research
Published: January 07, 2026
Targeting "undruggable" cancer proteins: pharmacological challenges and emerging strategies.
Journal: Translational cancer research
Published: December 19, 2025
Cephalochromin Effects in Triple-Negative Breast Cancer Cells: Apoptosis Induction and Modulation of Survival Pathways.
Journal: Journal of natural products
Published: December 04, 2025
Last Updated: 09/26/2026